Research Review of the Mechanism of IL-17 in the Treatment of Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nursing Science

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.12677/ns.2025.149209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety.

  2025cited by this paper
• Brain-wide mapping of immune receptors uncovers a neuromodulatory role of IL-17E and the receptor IL-17RB.

  2025cited by this paper
• Roles of Cytokines in Alzheimer’s Disease

  2024cited by this paper
• Modulation of Alzheimer’s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a

  2024cited by this paper
• IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice

  2023cited by this paper
• Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review

  2023cited by this paper
• Advances in the study of IL-17 in neurological diseases and mental disorders

  2023cited by this paper
• Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis

  2023cited by this paper
• IL-17 and IL-17-producing cells in protection versus pathology

  2022cited by this paper
• Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies

  2021cited by this paper
• Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

  2021cited by this paper
• IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease.

  2020cited by this paper
• Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

  2020cited by this paper
• IL-18 induced IL-23/IL-17 expression impairs Aβ clearance in cultured THP-1 and BV2 cells.

  2019cited by this paper
• Interleukine-17 Administration Modulates Adult Hippocampal Neurogenesis and Improves Spatial Learning in Mice

  2019cited by this paper
• Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory

  2019cited by this paper
• Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment

  2019cited by this paper
• Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation

  2017cited by this paper
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin

  2015cited by this paper
• Secukinumab in plaque psoriasis--results of two phase 3 trials.

  2014cited by this paper
• Increased Serum Levels of Interleukin-18, -23 and -17 in Chinese Patients with Alzheimer's Disease

  2014cited by this paper
• Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

  2013cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Cellular mechanisms of IL‐17‐induced blood‐brain barrier disruption

  2010cited by this paper
• In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis.

  2010cited by this paper
• Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

  2007cited by this paper
• Neuronal plasticity in memory and learning abilities: theoretical position and selective review.

  2006cited by this paper

• No citing papers are available for this paper.